15 April 2024 – For the fourth time after 2019, 2021 and 2022, EMBO is making the finances of its scientific publications public to provide transparency about the cost and the revenue from publishing the high quality, selective journals The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine. A fifth journal, Life Science Alliance, published in partnership with Rockefeller University Press and Cold Spring Harbor Press, is not included in this chart providing an overview of the cost and revenue structure of the four journals. All surplus is reinvested into EMBO activities supporting life scientists.
